57085-3
Organic acid newborn screen panel
Active
Term Description
Newborn screening dried blood spot analysis by tandem mass spectrometry (MS/MS) requires pre-processing the specimen with one of two alternative reagent methods referred to as derivatized and non-derivatized (or underivatized) methods. The methods are similar and nearly all analytes and ratios are identical with the limited number of exceptions noted in the description of the LOINC codes. Some labs choose to use the non-derivatized method because it may be faster or less expensive for their operations. There are no analytes which would be interpreted differently based on the method used to process the specimen so there is no need for different LOINC codes for the same compounds based on the reagents. In a few cases, a different LOINC code is used for the derivatized or non-derivatized tandem mass spectrometry (MS/MS) method because based on the reagents used in processing, different analytes are measured or different sets of analytes become isobaric, which means that they cannot be distinguished on the MS/MS because they have the same molecular weight after reagent processing.
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
57085-3 | Organic acid newborn screen panel | C | ||
Indent46744-9 | Organic acidemias newborn screen interpretation | C | ||
Indent57791-6 | Organic acidemia conditions suspected [Identifier] in DBS | C | ||
Indent57708-0 | Organic acidemias defects newborn screening comment-discussion | C | ||
Indent50157-7 | Acetylcarnitine (C2) [Moles/volume] in DBS | C | umol/L | |
Indent53237-4 | Acrylylcarnitine (C3:1) [Moles/volume] in DBS | C | umol/L | |
Indent53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS | C | umol/L | |
Indent53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS | C | {Ratio} | |
Indent53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS | C | {Ratio} | |
Indent53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS | C | {Ratio} | |
Indent54462-7 | Malonylcarnitine (C3-DC) [Moles/volume] in DBS | C | umol/L | |
Indent67708-8 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS | C | umol/L | |
Indent75213-9 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS | C | {ratio} | |
Indent53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | C | {Ratio} | |
Indent53166-5 | Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS | C | umol/L | |
Indent53167-3 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS | C | {Ratio} | |
Indent53168-1 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS | C | {Ratio} | |
Indent53169-9 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS | C | {Ratio} | |
Indent53170-7 | Tiglylcarnitine (C5:1) [Moles/volume] in DBS | C | umol/L | |
Indent45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS | C | umol/L | |
Indent75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS | {ratio} | ||
Indent67701-3 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | C | {Ratio} | |
Indent67710-4 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS | C | umol/L | |
Indent67711-2 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS | C | {Ratio} | |
Indent45216-9 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS | C | umol/L | |
Indent53238-2 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS | C | {Ratio} | |
Indent53239-0 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS | C | {Ratio} | |
Indent53240-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS | C | {Ratio} | |
Indent53401-6 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBS | C | {Ratio} | |
Indent50106-4 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS | C | umol/L | |
Indent53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS | C | {Ratio} | |
Indent53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS | C | {Ratio} | |
Indent53178-0 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS | C | umol/L | |
Indent53402-4 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS | C | {Ratio} | |
Indent53179-8 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS | C | {Ratio} | |
Indent45222-7 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS | C | umol/L | |
Indent67709-6 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS | C | umol/L | |
Indent53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS | C | {Ratio} | |
Indent53183-0 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS | C | umol/L | |
Indent53403-2 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS | C | {Ratio} | |
Indent53184-8 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS | C | {Ratio} | |
Indent53185-5 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS | C | {Ratio} | |
Indent53186-3 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | C | {Ratio} | |
Indent53187-1 | Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS | C | umol/L | |
Indent53165-7 | Formiminoglutamate [Moles/volume] in DBS | C | umol/L |
Fully-Specified Name
- Component
- Organic acid newborn screen panel
- Property
- -
- Time
- Pt
- System
- Bld.dot
- Scale
- -
- Method
Additional Names
- Long Common Name
- Organic acid newborn screen panel
- Short Name
- OA NB scn pnl DBS
- Display Name
- Organic acid NBS panel (DBS)
- Consumer Name Alpha Get Info
- Organic Acid NBS Panel, Dried blood spot
Basic Attributes
- Class
- PANEL.CHEM
- Type
- Laboratory
- First Released
- Version 2.29
- Last Updated
- Version 2.77
- Order vs. Observation
- Order
- Panel Type
- Panel
Member of these Panels
LOINC | Long Common Name |
---|---|
58092-8 | Acylcarnitine newborn screen panel |
104191-2 | Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel |
54089-8 | Newborn screening panel American Health Information Community (AHIC) |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Panel de monitoreo de ácido orgánico para recién nacidos: |
es-ES | Spanish (Spain) | Panel de cribado de ácidos orgánicos en el recién nacido: |
fr-FR | French (France) | Acides organiques dépistage néonatal panel: |
it-IT | Italian (Italy) | Acidi organici, panel screening neonatale: Synonyms: Chimica Panel screening neonatale degli acidi organici Punto nel tempo (episodio) Sangue Set di prescrizione chimica Spot sangue secco |
nl-NL | Dutch (Netherlands) | organische zuren pasgeborene screening panel: |
pt-BR | Portuguese (Brazil) | Ácidos Orgânicos, triagem neonatal, painel: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Органические кислоты новорождённый скрин панель: Synonyms: Кровь Кровь сухая капля Точка во времени; |
zh-CN | Chinese (China) | 有机酸新生儿筛查组套: Synonyms: 全血斑点(滤纸); |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=57085-3 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/57085-3
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://